Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

221 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 221 results

Testing effectiveness (Phase 2)Study completedNCT05727215
What this trial is testing

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

Who this might be right for
COVID-19
PT Bio Farma 150
Testing effectiveness (Phase 2)UnknownNCT05172193
What this trial is testing

Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

Who this might be right for
COVID-19
PT. Kimia Farma (Persero) Tbk 600
Large-scale testing (Phase 3)Study completedNCT04927065
What this trial is testing

Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 5,161
Large-scale testing (Phase 3)Study completedNCT05567471
What this trial is testing

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

Who this might be right for
COVID-19 Respiratory Infection
Bharat Biotech International Limited 875
Early research (Phase 1)Looking for participantsNCT06821100
What this trial is testing

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

Who this might be right for
Vaccine ResponseCOVID-19 VaccineImmune Response to Covid 19 Vaccination
The Methodist Hospital Research Institute 75
Large-scale testing (Phase 3)UnknownNCT05686161
What this trial is testing

MRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

Who this might be right for
ImmunogenicitySafetyEfficacy
Stemirna Therapeutics 600
Testing effectiveness (Phase 2)WithdrawnNCT05465902
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd.
Not applicableStudy completedNCT05438472
What this trial is testing

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

Who this might be right for
Myocarditis
University Hospital, Basel, Switzerland 835
Not applicableWithdrawnNCT05476822
What this trial is testing

Profiling Spike Protein Antibody Response Post COVID-19 Booster

Who this might be right for
COVID-19 BoosterSpike Protein IgG Antibody
David Grant U.S. Air Force Medical Center
Post-approval studies (Phase 4)UnknownNCT04961229
What this trial is testing

Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeImmunosuppression
dafna yahav 504
Not applicableLooking for participantsNCT06300853
What this trial is testing

Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.

Who this might be right for
COVID-19
IRCCS Sacro Cuore Don Calabria di Negrar 350
Early research (Phase 1)Study completedNCT06032000
What this trial is testing

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Who this might be right for
COVID-19 InfectionCOVID-19 Vaccine Adverse Reaction
Lemonex 20
Large-scale testing (Phase 3)UnknownNCT05911087
What this trial is testing

A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2

Who this might be right for
ImmunogenicitySafety
Stemirna Therapeutics 800
Not applicableStudy completedNCT05543993
What this trial is testing

COVID Booster in Pregnancy and Lactation

Who this might be right for
COVID-19
Thomas Jefferson University 150
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Not applicableStudy completedNCT06130410
What this trial is testing

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

Who this might be right for
SARS-CoV-2COVID-19
Pfizer 25
Early research (Phase 1)WithdrawnNCT05609045
What this trial is testing

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

Who this might be right for
COVID-19 Pandemic
Wuhan Rhegen Biotechnology Co., Ltd.
Not applicableUnknownNCT05468021
What this trial is testing

Puerto Rico COVID-19 Vaccine Uptake Study

Who this might be right for
COVID-19
University of Puerto Rico 394
Early research (Phase 1)Study completedNCT05181709
What this trial is testing

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

Who this might be right for
SARS-CoV-2
Sean Liu 35
Not applicableStudy completedNCT05373459
What this trial is testing

Effect of a Third COVID-19 Booster Among Health Care Workers

Who this might be right for
COVID-19 Vaccines
Hong Kong Sanatorium & Hospital 3,167
Load More Results